We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4.17B
AUM Growth
+$157M
Cap. Flow
-$34.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
10.45%
Holding
265
New
16
Increased
151
Reduced
45
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 24.7%
2 Industrials 15.95%
3 Healthcare 15.09%
4 Financials 14.66%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
101
Intuitive Surgical
ISRG
$134B
$16.3M 0.39%
140,535
MIME
102
DELISTED
Mimecast Limited
MIME
$16.3M 0.39%
573,886
+19,409
+4% +$534K
CSGP icon
103
CoStar Group
CSGP
$12.3B
$16M 0.38%
595,760
LGF.B
104
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$16M 0.38%
502,434
+17,065
+4% +$477K
JELD icon
105
JELD-WEN Holding
JELD
$164M
$15.9M 0.38%
446,978
+164,950
+58% +$5.22M
ATVI
106
DELISTED
Activision Blizzard
ATVI
$15.7M 0.38%
243,479
GKOS icon
107
Glaukos
GKOS
$10.6B
$15.5M 0.37%
469,154
+140,130
+43% +$5.32M
HOME
108
DELISTED
At Home Group Inc.
HOME
$15.4M 0.37%
672,391
+85,922
+15% +$1.98M
FANG icon
109
Diamondback Energy
FANG
$52.7B
$15.3M 0.37%
156,298
+5,310
+4% +$489K
TSRO
110
DELISTED
TESARO, Inc.
TSRO
$15.2M 0.37%
118,090
+18,743
+19% +$2.33M
PCRX icon
111
Pacira BioSciences
PCRX
$997M
$15.2M 0.36%
404,141
+48,859
+14% +$1.97M
AMT icon
112
American Tower
AMT
$80.4B
$15.2M 0.36%
110,887
GWRE icon
113
Guidewire Software
GWRE
$14.2B
$14.9M 0.36%
191,894
VSH icon
114
Vishay Intertechnology
VSH
$5.43B
$14.7M 0.35%
781,178
+15,940
+2% +$280K
VC icon
115
Visteon
VC
$2.78B
$14.7M 0.35%
118,649
+2,422
+2% +$275K
HMHC
116
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$14.6M 0.35%
1,210,952
+41,141
+4% +$463K
ESPR
117
DELISTED
Esperion Therapeutics
ESPR
$14.5M 0.35%
290,027
-28,640
-9% -$1.38M
FLXN
118
DELISTED
Flexion Therapeutics, Inc.
FLXN
$14.4M 0.35%
595,211
-114,052
-16% -$2.68M
TIVO
119
DELISTED
Tivo Inc
TIVO
$13.9M 0.33%
698,314
+14,221
+2% +$266K
DKS icon
120
Dick's Sporting Goods
DKS
$18.7B
$13.8M 0.33%
511,302
-99,003
-16% -$3.15M
MGLN
121
DELISTED
Magellan Health Services, Inc.
MGLN
$13.7M 0.33%
159,097
+3,241
+2% +$255K
IBTX
122
DELISTED
Independent Bank Group, Inc.
IBTX
$13.7M 0.33%
227,122
+4,527
+2% +$263K
TPH
123
DELISTED
Tri Pointe Homes
TPH
$13.7M 0.33%
991,098
+20,263
+2% +$269K
ALXN
124
DELISTED
Alexion Pharmaceuticals
ALXN
$13.7M 0.33%
97,420
MMSI icon
125
Merit Medical Systems
MMSI
$5.32B
$13.6M 0.33%
321,756
+6,522
+2% +$263K

Similar funds

Peregrine Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Peregrine Capital Management held 265 positions worth $4.17B, up 3.9% from $4.01B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Peregrine Capital Management's Q3 2017 filing shows 16 new, 151 increased, 45 reduced and 24 closed positions. Its largest new stake was Knight Transportation: 568,498 shares worth $23.6M. The largest sale was Spectranetics Corp, an estimated $34.9M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.

  • Peregrine Capital Management's largest Q3 2017 buy was Knight Transportation: 568,498 shares worth $23.6M.
  • Peregrine Capital Management added most to Caesars Entertainment in Q3 2017, an estimated $19.9M increase.
  • Peregrine Capital Management's biggest Q3 2017 reduction was PENN Entertainment, cutting an estimated $8.63M.
  • Peregrine Capital Management fully exited Spectranetics Corp in Q3 2017, selling an estimated $34.9M.
  • Peregrine Capital Management's ten largest holdings make up 10% of its $4.17B portfolio in Q3 2017.
  • Peregrine Capital Management opened 16 new positions and closed 24 in Q3 2017.
  • Peregrine Capital Management's portfolio value rose 3.9% quarter-over-quarter to $4.17B.

Based on Peregrine Capital Management's 13F filing for Q3 2017, filed 25 Oct 2017.